Clinical Trial Update: Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a serotonin/dopamine antagonist for cocaine-related disorders has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine-related Disorders

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 2 | Status: TERMINATED